MASSDEVICE ON CALL — Medtech titan Covidien (NYSE:COV) cut the ribbon on a new training center in Sao Paulo, Brazil, the home country of president & CEO Jose Almeida.
The company said that the new 3,000-square meter facility is located near the Ponte Estaiada, which is not far from the Instituto Maua de Tecnologia where Almeida received a Bachelor of Science in mechanical engineering.
The facility is the 1st of its kind in Latin America, featuring courses in mechanical ventilation, monitoring of vital signs, surgical procedures and minimally invasive surgeries, Covidien said. The company can host 120 sessions and train 2,000 healthcare professionals each year.
"By creating the [Covidien Center of Innovation], Covidien is helping fill the gap that currently exists in the education of health care professionals in new and less invasive surgical techniques in Brazil, which can help patients and the region by speeding recovery times and reducing health care costs," vice president & general manager Ermano Moraes said in prepared remarks. "In addition to education, our R&D engineers will observe, listen and work closely with health care professionals to uncover opportunities for locally tailored solutions that address unmet needs in Brazil and Latin America."
Covidien also has centers in China, South Korea, India and Turkey.
Cognex sells its 1 millionth system to Medtronic
Massachusetts-based Cognex Corp. (NSDQ:CGNX) sold 1 millionth In-Sight vision system, which was hand-delivered to Medtronic (NYSE:MDT) this month.
Read more
Telehealth interest growing among hospitals
More than 40% of hospitals surveyed by HIMSS said that they’d used telemedicine technologies, most of them with video messaging services.
Read more
FDA launches medtech adverse event database API
The FDA launched an API (application programming interface) that opens more than 20 years’ of medical device adverse event reporting data.
Read more
Study: Race and ethnicity don’t change heart implant outcomes
A new study of survival outcomes for patients receiving implantable heart devices finds that racial and ethnic minorities benefit as much as white patients.
Read more
